T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: Comparison of gene expression profiles between human tonsillar and lung-cultured mast cells

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 5247-5257

  Kashiwakura, Jun Ichi ^a   Yokoi, Hidenori ^b   Saito, Hirohisa ^a,c   Okayama, Yoshimichi ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD134 ANTIGEN;

ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS CELL; MAST CELL; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TONSIL CELL; UPREGULATION;

EID: 6344254397     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.5247     Document Type: Article

References (59)

1. Wedemeyer, J., M. Tsai, and S. J. Galli. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:624.
2. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381:77.
3. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:813.
4. Mannel, D. N., L. Hultner, and B. Echtenacher. 1996. Critical protective role of mast cell-derived tumour necrosis factor in bacterial infection. Res. Immunol. 147:491.
5. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16:157.
6. Ji, H., A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist. 2002. Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J. Exp. Med. 196:77.
7. Robbie-Ryan, M., M. B. Tanzola, V. H. Secor, and M. A. Brown. 2003. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170:1630.
8. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4:1199.
9. Wang, H. W., N. Tedla, A. R. Lloyd, D. Wakefield, and P. H. McNeil. 1998. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102:1617.
10. Friend, D. S., M. F. Gurish, K. F. Austen, J. Hunt, and R. L. Stevens. 2000. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J. Immunol. 165:344.
11. Malaviya, R., E. A. Ross, J. I. MacGregor, T. Ikeda, J. R. Little, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152:1907.
12. Malaviya, R., N. J. Twesten, E. A. Ross, S. N. Abraham, and J. D. Pfeifer. 1996. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156:1490.
13. + T cell hybridomas by human mast cells through superantigen presentation. J. Leukocyte Biol. 66:105.
14. Dimitriadou, V., S. Mecheri, M. Koutsilieris, W. Fraser, R. Al-Daccak, and W. Mourad. 1998. Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. J. Leukocyte Biol. 64:791.
15. Tkaczyk, C., I. Villa, R. Peronet, B. David, and S. Mecheri. 1999. FcεRI-mediated antigen endocytosis turns interferon-γ-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology 97:333.
16. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745.
17. Baum, P. R., R. B. Gayle, 3rd, F. Ramsdell, S. Srinivasan, R. A. Sorensen, M. L. Watson, M. F. Seldin, E. Baker, G. R. Sutherland, K. N. Clifford, et al. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:3992.
18. Wen, T., J. Bukczynski, and T. H. Watts. 2002. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol. 168:4897.
19. - T cells by 4-1BB ligand. Eur. J. Immunol. 33:446.
20. Ukyo, N., T. Hori, S. Yanagita, T. Ishikawa, and T. Uchiyama. 2003. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response. Immunology 109:226.
21. + T-cell activation, protection from apoptosis, and enhanced cytokine production. Cell. Immunol. 222:45.
22. + T cells into high IL-4-producing effectors. Blood 92:3338.
23. Tanaka, H., C. E. Demeure, M. Rubio, G. Delespesse, and M. Sarfati. 2000. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors: role of stimulator/responder ratio. J. Exp. Med. 192:405.
24. Akiba, H., Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura. 2000. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J. Exp. Med. 191:375.
25. Salek-Ardakani, S., J. Song, B. S. Halteman, A. G. Jember, H. Akiba, H. Yagita, and M. Croft. 2003. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J. Exp. Med. 198:315.
26. Linton, P. J., B. Bautista, E. Biederman, E. S. Bradley, J. Harbertson, R. M. Kondrack, R. C. Padrick, and L. M. Bradley. 2003. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 197:875.
27. Okayama, Y., R. C. Benyon, P. H. Rees, M. A. Lowman, K. Hillier, and M. K. Church. 1992. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin. Exp. Allergy 22:401.
28. Okayama, Y., and M. K. Church. 1992. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int. Arch. Allergy Immunol. 97:216.
29. 2 release from mast cells of human lung, tonsil, and skin. Allergy 49:246.
30. Okumura, S., J. Kashiwakura, H. Tomita, K. Matsumoto, T. Nakajima, H. Saito, and Y. Okayama. 2003. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI. Blood 102:2547.
31. Iida, M., K. Matsumoto, H. Tomita, T. Nakajima, A. Akasawa, N. Y. Ohtani, N. L. Yoshida, K. Matsui, A. Nakada, Y. Sugita, et al. 2001. Selective down-regulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 97:1016.
32. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986.
33. Baugh, L. R., A. A. Hill, E. L. Brown, and C. P. Hunter. 2001. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res. 29:E29
34. Nakajima, T., K. Matsumoto, H. Suto, K. Tanaka, M. Ebisawa, H. Tomita, K. Yuki, T. Katsunuma, A. Akasawa, R. Hashida, et al. 2001. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 98:1127.
35. Nakajima, T., N. Inagaki, H. Tanaka, A. Tanaka, M. Yoshikawa, M. Tamari, K. Hasegawa, K. Matsumoto, H. Tachimoto, M. Ebisawa, et al. 2002. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison. Blood 100:3861.
36. Shen, H., M. Zhang, G. Y. Minuk, and Y. Gong. 2002. Different effects of rat interferon α, β and γ on rat hepatic stellate cell proliferation and activation. BMC Cell Biol. 3:9.
37. Oda, N., K. Minoguchi, A. Tanaka, T. Yokoe, H. Minoguchi, H. Matsuo, M. Nakashima, T. Tasaki, and M. Adachi. 2002. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells. Clin. Exp. Allergy 32:1782.
38. Li, Z., Y. Niwa, K. Rokutan, and Y. Nakaya. 1999. Expression of endothelin-1 in macrophages and mast cells in hyperplastic human tonsils. FEBS Lett. 457:381.
39. Furitsu, T., H. Saito, A. M. Dvorak, L. B. Schwartz, A. M. Irani, J. F. Burdick, K. Ishizaka, and T. Ishizaka. 1989. Development of human mast cells in vitro. Proc. Natl. Acad. Sci. USA 86:10039.
40. Nomura, I., T. Katsunuma, K. Matsumoto, M. Iida, H. Tomita, M. Tomikawa, H. Kawahara, A. Akasawa, R. Pawankar, and H. Saito. 2001. Human mast cell progenitors in peripheral blood from atopic subjects with high IgE levels. Clin. Exp. Allergy 31:1424.
41. - cell population. Blood 84:2489.
42. Fureder, W., H. C. Bankl, J. Toth, S. Walchshofer, W. Sperr, H. Agis, H. Semper, C. Sillaber, K. Lechner, and P. Valent. 1997. Immunophenotypic and functional characterization of human tonsillar mast cells. J. Leukocyte Biol. 61:592.
43. Lowman, M. A., P. H. Rees, R. C. Benyon, and M. K. Church. 1988. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J. Allergy Clin. Immunol. 81:590.
44. Heard, B. E., A. Dewar, and B. Corrin. 1992. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis: ultrastructure and cell perimeter measurements. J. Pathol. 166:303.
45. Kawanami, O., V. J. Ferrans, J. D. Fulmer, and R. G. Crystal. 1979. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40:717.
46. Carreno, B. M, and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29.
47. Sharpe, A. H, and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116.
48. Kundig, T. M., A. Shahinian, K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41.
49. Inamura, N., Y. A. Mekori, S. P. Bhattacharyya, P. J. Bianchine, and D. D. Metcalfe. 1998. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160:4026.
50. Bhattacharyya, S. P., I. Drucker, T. Reshef, A. S. Kirshenbaum, D. D. Metcalfe, and Y. A. Mekori. 1998. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukocyte Biol. 63:337.
51. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
52. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827.
53. Roehm, N. W., G. H. Rodgers, S. M. Hatfield, and A. L. Glasebrook. 1991. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142:257.
54. Jippo, T., Y. M. Lee, Y. Ge, D. K. Kim, M. Okabe, and Y. Kitamura. 2001. Tissue-dependent alteration of protease expression phenotype in murine peritoneal mast cells that were genetically labeled with green fluorescent protein. Am. J. Pathol. 158:1695.
55. Irani, A. M., T. R. Bradford, C. L. Kepley, N. M. Schechter, and L. B. Schwartz. 1989. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37:1509.
56. Tedla, N., H. W. Wang, H. P. McNeil, N. Di Girolamo, T. Hampartzoumian, D. Wakefield, and A. Lloyd. 1998. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1α and MIP-1β. J. Immunol. 161:5663.
57. Sayama, K., M. Diehn, K. Matsuda, C. Lunderius, M. Tsai, S. Y. Tam, D. Botstein, P. O. Brown, and S. J. Galli. 2002. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3:5.
58. Nilsson, G., and L. B. Schwatz. 1995. Mast-cell heterogeneity: structure and mediators. In Asthma and Rhinitis. W. W. Busse and S. T. Holgate, eds. Blackwell, Boston, p. 195.
59. Church, M. K., Y. Okayama, and P. Bradding. 1995. Functional mast-cell heterogeneity. In Asthma and Rhinitis. W. W. Busse and S. T. Holgate, eds. Blackwell, Boston, p. 209.